Cancer targeting Gene-Viro-Therapy of liver carcinoma by dual-regulated oncolytic adenovirus armed with TRAIL gene.
about
Targeting adeno-associated virus and adenoviral gene therapy for hepatocellular carcinomaUp-regulation of Mcl-1 and Bak by coronavirus infection of human, avian and animal cells modulates apoptosis and viral replicationA novel capsid-modified oncolytic recombinant adenovirus type 5 for tumor-targeting gene therapy by intravenous routeTumor suppressor BLU inhibits proliferation of nasopharyngeal carcinoma cells by regulation of cell cycle, c-Jun N-terminal kinase and the cyclin D1 promoter.Potent and specific antitumor effect for colorectal cancer by CEA and Rb double regulated oncolytic adenovirus harboring ST13 gene.Enhancing the bystander killing effect of an oncolytic HSV by arming it with a secretable apoptosis activator.Gene therapy for colorectal cancer by an oncolytic adenovirus that targets loss of the insulin-like growth factor 2 imprinting systemA new oncolytic adenoviral vector carrying dual tumour suppressor genes shows potent anti-tumour effectThe potential application of a transcriptionally regulated oncolytic herpes simplex virus for human cancer therapy.Tumor suppressor in lung cancer-1 (TSLC1) mediated by dual-regulated oncolytic adenovirus exerts specific antitumor actions in a mouse model.Nanoparticles-mediated drug delivery approaches for cancer targeting: a review.Hepatocellular carcinoma: targeting of oncogenic signaling networks in TRAIL resistant cancer cells.Delivery of improved oncolytic adenoviruses by mesenchymal stromal cells for elimination of tumorigenic pancreatic cancer cells.Glial fibrillary acidic protein promoters direct adenovirus early 1A gene and human telomerase reverse transcriptase promoters direct sodium iodide symporter expression for malignant glioma radioiodine therapy.Gene-viro-therapy targeting liver cancer by a dual-regulated oncolytic adenoviral vector harboring IL-24 and TRAIL.Treatment of pancreatic cancer using an oncolytic virus harboring the lipocalin-2 gene.Promoter-Operating Targeted Expression of Gene Therapy in Cancer: Current Stage and Prospect.
P2860
Q26772315-901748CB-94C0-47FA-BDC4-685DC49F632BQ28478856-A80B4BB3-4A3F-43C4-88B8-FD6A17AD3F4BQ28817910-EE07A334-D615-45EE-902E-5EB63EB7D51BQ34315482-FAD11FA9-2DAD-4EC6-B410-A1ED87086760Q34450950-00265CCC-D9EF-4A59-998E-DF9F88523524Q35154965-5ADA35BD-499F-4AA1-9116-B1BDAB9309D3Q36538951-224582E7-9EF6-4569-8CDA-EEF9379250B6Q37295187-FEFD656C-F546-4AAD-B9C9-3B91BADC5F9FQ37459624-06482F7B-3AE3-4D23-80B5-DDAC9991655BQ37728885-EEA375CA-801F-4016-97F8-326C8E1AF01BQ38032893-8D6F7711-506B-4BD5-B300-098E5C9F002EQ38231045-06279523-3662-4D98-9A7F-67B08FA2A174Q38914555-ACEC5B06-4F21-4C96-9658-7B5670DD7294Q38939127-889D56CF-8C2C-4D18-8CB8-E4AFB7C6D64DQ39462019-E5E25E26-51CB-4DCE-A5F5-6529EBBB1082Q45358201-58690675-F976-4B3E-A5F9-A36F8201A068Q55239952-ADEEBBB6-9A6C-491D-B549-4DEE72618B50
P2860
Cancer targeting Gene-Viro-Therapy of liver carcinoma by dual-regulated oncolytic adenovirus armed with TRAIL gene.
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
2011年论文
@zh
2011年论文
@zh-cn
name
Cancer targeting Gene-Viro-The ...... novirus armed with TRAIL gene.
@en
Cancer targeting Gene-Viro-The ...... novirus armed with TRAIL gene.
@nl
type
label
Cancer targeting Gene-Viro-The ...... novirus armed with TRAIL gene.
@en
Cancer targeting Gene-Viro-The ...... novirus armed with TRAIL gene.
@nl
prefLabel
Cancer targeting Gene-Viro-The ...... novirus armed with TRAIL gene.
@en
Cancer targeting Gene-Viro-The ...... novirus armed with TRAIL gene.
@nl
P2093
P2860
P356
P1433
P1476
Cancer targeting Gene-Viro-The ...... novirus armed with TRAIL gene.
@en
P2093
P2860
P2888
P304
P356
10.1038/GT.2011.16
P577
2011-03-17T00:00:00Z